The notices it replaced
- Reissues: RFA-NS-16-013 Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate the Discovery of Neurotherapeutics (R21/R33)
Replaced by PAR-21-123.
Who won it before
12 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,329,977 in first-year total cost, median $399,319.
Most frequent study sections
- Neurological Sciences and Disorders B Study Section[NSD-B]7
- Neurological Sciences and Disorders A Study Section[NSD-A]5
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- IOWA STATE UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
- MICHIGAN STATE UNIVERSITY1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | A Phenotype-Optimized Zebrafish Model of Progressive Supranuclear Palsy1R61NS125280-01 | BURTON, EDWARD ALANSCHOPPIK, DAVID | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $497,436 | NSD |
| 2020 | iPSC-derived neurovascular tissue model of cerebral amyloiad angiopathy1R61NS112445-01A1 | LIPPMANN, ETHAN | VANDERBILT UNIVERSITY, TN | $831,660 | NSD |
| 2020 | Development and Validation of a Clinically Relevant Animal Pain Model1R61NS116423-01 | SHEN, SHIQIAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $420,000 | NSD |
| 2020 | Modeling West Syndrome to Prevent Neurobehavioral Disabilities1R61NS112553-01A1 | SWANN, JOHN WILLIAM | BAYLOR COLLEGE OF MEDICINE, TX | $400,938 | NSD |
| 2019 | Combining synucleinopathy and mitochondrial deficits in a novel mouse model of Parkinsons disease1R21NS106078-01A1 · under RFA-NS-16-013 | BRUNDIN, PATRIKKORDOWER, JEFFREY H | VAN ANDEL RESEARCH INSTITUTE, MI | $471,170 | NSD |
| 2019 | Development and Validation of a Zebrafish Model for Vanishing White Matter Disease1R21NS109441-01 · under RFA-NS-16-013 | BONKOWSKY, JOSH LEITCH | UNIVERSITY OF UTAH, UT | $376,556 | NSD |
| 2019 | Validation of a novel mouse model of temporal lobe epilepsy1R61NS112549-01 | PEREZ-REYES, EDWARD | UNIVERSITY OF VIRGINIA, VA | $363,375 | NSD |
| 2018 | Internal and external validation of a porcine dystrophinopathy model1R21NS106112-01 · under RFA-NS-16-013 | SELSBY, JOSHUA T | IOWA STATE UNIVERSITY, IA | $341,138 | NSD |
| 2017 | Development and validation of a genetically engineered model of neurofibromatosis type 2 to facilitate discovery of neurotherapeutics1R21NS099417-01A1 · under RFA-NS-16-013 | KISSIL, JOSEPH | SCRIPPS FLORIDA, FL | $477,230 | NSD |
| 2017 | The Rat Pre-Formed Alpha-Synuclein Fibril Model of Parkinson's Disease1R21NS099416-01A1 · under RFA-NS-16-013 | SORTWELL, CARYL E | MICHIGAN STATE UNIVERSITY, MI | $397,700 | NSD |
| 2017 | Innovation Grant to Nurture Initial Translational Efforts (IGNITE) to Neurotherapeutic Approaches in Minipig Models of PKU Disorders1R21NS099450-01A1 · under RFA-NS-16-013 | DOBROWOLSKI, STEVEN FNICHOLLS, ROBERT D | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $383,610 | NSD |
| 2017 | New GAA expansion mouse for efficacy studies of treatments for Friedreich ataxia1R21NS101145-01 · under RFA-NS-16-013 | NAPIERALA, MAREK | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $369,164 | NSD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.